Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.850
+0.050 (1.79%)
Nov 21, 2024, 1:24 PM EST - Market open
Autolus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 10.09 | 1.7 | 6.36 | 2.33 | 1.72 | 2.91 | Upgrade
|
| Revenue | 10.09 | 1.7 | 6.36 | 2.33 | 1.72 | 2.91 | Upgrade
|
| Revenue Growth (YoY) | 82.71% | -73.30% | 172.96% | 35.86% | -41.02% | 97.55% | Upgrade
|
| Cost of Revenue | 32.62 | 130.48 | 117.35 | 110.84 | 134.89 | 105.42 | Upgrade
|
| Gross Profit | -22.53 | -128.78 | -110.99 | -108.51 | -133.17 | -102.51 | Upgrade
|
| Selling, General & Admin | 83.14 | 46.75 | 31.9 | 31.87 | 34.97 | 39.45 | Upgrade
|
| Research & Development | 107.61 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 190.74 | 46.75 | 31.9 | 31.87 | 34.97 | 39.45 | Upgrade
|
| Operating Income | -213.28 | -175.53 | -142.89 | -140.37 | -168.15 | -141.96 | Upgrade
|
| Interest Expense | -70.26 | -45.07 | -8.91 | -1.11 | - | - | Upgrade
|
| Interest & Investment Income | 27.92 | 13.51 | 1.71 | 0.26 | 0.54 | 2.54 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.37 | 2.6 | 1.8 | -2.3 | -0.2 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.36 | 0.26 | 0.34 | 0.16 | 1.55 | 4.51 | Upgrade
|
| EBT Excluding Unusual Items | -264.63 | -204.23 | -147.95 | -143.36 | -166.26 | -134.91 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.22 | -3.79 | -0.52 | -0.68 | - | - | Upgrade
|
| Asset Writedown | -0.41 | -0.38 | - | - | - | -4.1 | Upgrade
|
| Other Unusual Items | - | - | -0.1 | 2 | - | - | Upgrade
|
| Pretax Income | -265.27 | -208.4 | -148.57 | -142.04 | -166.26 | -139.01 | Upgrade
|
| Income Tax Expense | 4.96 | -0.02 | 0.27 | 0.06 | -24.16 | -15.16 | Upgrade
|
| Net Income | -270.23 | -208.38 | -148.84 | -142.1 | -142.09 | -123.85 | Upgrade
|
| Net Income to Common | -270.23 | -208.38 | -148.84 | -142.1 | -142.09 | -123.85 | Upgrade
|
| Shares Outstanding (Basic) | 232 | 174 | 95 | 72 | 52 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 232 | 174 | 95 | 72 | 52 | 43 | Upgrade
|
| Shares Change (YoY) | 47.73% | 83.11% | 31.78% | 39.81% | 19.72% | 25.92% | Upgrade
|
| EPS (Basic) | -1.16 | -1.20 | -1.57 | -1.97 | -2.76 | -2.88 | Upgrade
|
| EPS (Diluted) | -1.17 | -1.20 | -1.57 | -1.97 | -2.76 | -2.88 | Upgrade
|
| Free Cash Flow | -205.61 | -156.57 | -123.15 | -126.72 | -132.44 | -119.83 | Upgrade
|
| Free Cash Flow Per Share | -0.89 | -0.90 | -1.30 | -1.76 | -2.57 | -2.78 | Upgrade
|
| Gross Margin | -223.30% | - | - | - | - | - | Upgrade
|
| Operating Margin | -2113.54% | -10337.34% | -2246.75% | -6024.64% | -9804.37% | -4881.77% | Upgrade
|
| Profit Margin | -2677.90% | -12272.26% | -2340.24% | -6098.54% | -8285.36% | -4258.91% | Upgrade
|
| Free Cash Flow Margin | -2037.56% | -9221.02% | -1936.31% | -5438.54% | -7722.39% | -4120.53% | Upgrade
|
| EBITDA | -205.86 | -168.96 | -135.54 | -132.01 | -162.58 | -137.4 | Upgrade
|
| D&A For EBITDA | 7.41 | 6.57 | 7.36 | 8.37 | 5.57 | 4.56 | Upgrade
|
| EBIT | -213.28 | -175.53 | -142.89 | -140.37 | -168.15 | -141.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.